The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
about
Effectiveness of second generation antipsychotics: a systematic review of randomized trialsAntipsychotic drug treatment for elderly people with late-onset schizophreniaOlanzapine for schizophreniaRisperidone versus olanzapine for schizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Almost all antipsychotics result in weight gain: a meta-analysis.Elderly patients with schizophrenia and depression: diagnosis and treatmentCo-occurring depressive symptoms in the older patient with schizophrenia.Quality of life in schizophrenic patients.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).The relationship between patient satisfaction and treatment outcomes in schizophrenia.Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design featuresPaliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania.Management of schizophrenia in late life with antipsychotic medications: a qualitative review.Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia
P2860
Q21260262-2C33B227-E149-41AD-90B4-9BC6D11802EEQ24203649-7A9ED674-B0DF-401C-A8E1-F914A54664E2Q24244031-3F5D39DE-E175-4557-B6EB-EB247D6A923AQ24246232-6CB7D9E2-FEC1-4411-8ED3-436B3067A4FAQ33235110-D5AA48ED-9862-4B95-9E44-A8B321664D5DQ33545458-4FCFE105-8CB5-4AA7-BD11-5C44FC867FB5Q34653803-AF390C5E-DABB-487D-9ACA-D9C11BDD4245Q34661499-99B31F45-471B-4FF9-9A5A-BE80855A67E7Q34707472-FF2416CD-DD9A-49FD-8346-F245B801F74EQ35008098-798A6F92-C6D3-4768-9418-1C4BED4ABAE5Q35236921-5CCF971F-8F3A-4AC1-9332-81C500F485D5Q35826495-346042AF-4B09-4A7E-81F7-13AB9E9AFA64Q36626251-83784712-B574-4B61-A643-C81B5869545EQ37227479-6847CD01-BF1B-4864-AEBD-BEB1AF7A3415Q37790388-0683625F-DB2F-4926-A6E6-81514919112FQ37960898-BDF4A18B-EAB7-432C-9148-83E2AB5F59AAQ41682303-01F6B006-4B4C-43C4-B70D-25EEC63D5DE5Q47390596-1410E39A-93F4-4EF0-92FF-B821009E2789Q50867891-61E879BA-720A-4047-BC45-484BC19C5211Q57403338-726D9839-E876-4F92-9CC7-254D0029C692
P2860
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The impact upon extra-pyramida ...... y patients with schizophrenia.
@en
The impact upon extra-pyramida ...... y patients with schizophrenia.
@nl
type
label
The impact upon extra-pyramida ...... y patients with schizophrenia.
@en
The impact upon extra-pyramida ...... y patients with schizophrenia.
@nl
prefLabel
The impact upon extra-pyramida ...... y patients with schizophrenia.
@en
The impact upon extra-pyramida ...... y patients with schizophrenia.
@nl
P2093
P2860
P356
P1476
The impact upon extra-pyramida ...... ly patients with schizophrenia
@en
P2093
C W Ritchie
S Macfarlane
P2860
P304
P356
10.1002/GPS.862
P407
P577
2003-05-01T00:00:00Z